According to a new report, published by KBV research, The Global Syphilis Testing Market size is expected to reach $1.5 billion by 2028, rising at a market growth of 5.6% CAGR during the forecast period.
The Laboratory testing segment acquired maximum revenue share in the Global Syphilis Testing Market by Location of Testing in 2021, thereby, achieving a market value of $1.1 billion by 2028. It is because blood test is frequently used to diagnose syphilis. A health care expert would collect a blood test from a vein in the arm using a tiny needle during a blood test. A small amount of blood would be gathered into a test tube or vial once the needle is inserted. When the needle goes in or out, it may sting a little later on the blood sample is taken to the laboratory and tests are done afterwards.
The North America market dominated the Global Syphilis Testing Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $539.7 million by 2028. The Europe market is estimated to witness a CAGR of 5.2% during (2022 - 2028). Additionally, The Asia Pacific market would experience a CAGR of 6.2% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/syphilis-testing-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Siemens Healthineers AG, Abbott Laboratories, DiaSorin S.p.A. (Luminex Corporation), Hologic, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Danaher Corporation (Cepheid), and F. Hoffmann-La Roche Ltd.
By Type
By Location of Testing
By Geography
Companies Profiled
Unique Offerings 
